Bajaj Healthcare Limited has intimated the stock exchanges about an upcoming meeting of its Board of Directors. The meeting is scheduled to be held on Monday, July 20, 2026. The primary agenda for this meeting is to consider and approve the Un-audited Financial Results of the Company for the quarter ended June 30, 2026 (Q1 FY27).
Furthermore, the company has confirmed the continuation of its trading window closure. Referring to a prior notice dated June 24, 2026, and in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's internal Code of Conduct, the Trading Window for dealing in the company's securities remains closed. This closure is effective for all Insiders and Designated Persons, including their immediate relatives, from July 01, 2026. The trading window will reopen only after the expiry of 48 hours following the public declaration of the Un-audited Financial Results for the quarter ended June 30, 2026.
The disclosure was signed and submitted by Monica Tanwar, Company Secretary & Compliance Officer, on behalf of Bajaj Healthcare Limited.